Real-time monitoring of vancomycin using a split-aptamer surface plasmon resonance biosensor
The Analyst · 2025
DOI: 10.1039/d4an01226g ↗Kurz gefasst
Fachartikel in der Zeitschrift The Analyst, 2025. Verfasst von Cátia Santa und 5 weiteren Autor:innen. Beteiligte Einrichtung: BioMed X Institute, Heidelberg, Germany. sergelen@bio.mx. Hauptthemen laut MEDLINE: Surface Plasmon Resonance, Aptamers, Nucleotide, Vancomycin, Limit of Detection. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Boehringer Ingelheim.
Abstract (Originalsprache)
The split-aptamer assay exploits the balance between aptamer affinity and structure for real-time monitoring of vancomycin on SPR. Further optimization improved sensitivity, while retaining repeatability under physiologically relevant conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- BioMed X Institute, Heidelberg, Germany. sergelen@bio.mx.
- Faculty of Biotechnology, Mannheim University of Applied Sciences, Germany.
- School of Biological and Health Systems Engineering, Arizona State University, USA.
- Boehringer Ingelheim Pharma GmbH & Co. KG, CNS Research, Germany.
Förderung
- Boehringer Ingelheim
Zitieren
APA
Santa, C., Park, S., Gejt, A., Clark, H. A., Hengerer, B., & Sergelen, K. (2025). Real-time monitoring of vancomycin using a split-aptamer surface plasmon resonance biosensor. The Analyst. https://doi.org/10.1039/d4an01226g
Vancouver
Santa C, Park S, Gejt A, Clark HA, Hengerer B, Sergelen K. Real-time monitoring of vancomycin using a split-aptamer surface plasmon resonance biosensor. The Analyst. 2025. doi:10.1039/d4an01226g
BibTeX
@article{Santa2025,
author = {Santa, Cátia and Park, Soohyun and Gejt, Artur and Clark, Heather A and Hengerer, Bastian and Sergelen, Khulan},
title = {Real-time monitoring of vancomycin using a split-aptamer surface plasmon resonance biosensor},
journal = {The Analyst},
year = {2025},
doi = {10.1039/d4an01226g}
}
EUVIMED